Magdy R, Mohammed Z, Hassan A, Ali M, Ibrahim A, Adel S, Hussein M
Department of Neurology, Cairo University, Cairo, Egypt.
Department of Public Health and Community Medicine, Beni-Suef University, Beni-Suef, Egypt.
Rev Neurol (Paris). 2023 Oct 26. doi: 10.1016/j.neurol.2023.08.018.
Parkinson's disease sleep scale (PDSS) was recommended by the Movement Disorder Society task force for screening and grading the severity of sleep problems in Parkinson's disease (PD). This work aimed to examine the validity and reliability of an Arabic version of PDSS-2.
This cross-sectional study was carried out on 133 patients fulfilling diagnostic criteria for PD. The patients were clinically assessed using the following scales: Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), modified Hoehn and Yahr Scale (H&Y), non-motor symptoms scale (NMSS), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). PDSS-2 scale was translated according to approved translation standards into Arabic and back-translated into English. Patients were asked to respond based on their experience in the last week.
The mean PDSS2 score for the included PD patients was 17±10. Cronbach's α coefficient value was 0.89, indicating good internal consistency. Most items showed high item-total correlation; the lowest was 0.375, considered higher than the conventional cut-off of 0.3. Test-retest reliability showed good agreement (ICC: 0.848). The exploratory factor analysis showed that items had been loaded over four factors. Total PDSS-2 score was positively correlated to age, disease duration, modified H&Y scale, MDS-UPDRS, NMSS, BDI, and global PSQI score. A cut-off point of 13 could differentiate poor sleepers from good sleepers with 91% sensitivity and 70% specificity (AUC 0.893, P<0.001).
The Arabic version of PDSS-2 has appropriate validity and can be reliably used for assessing sleep-related problems in Arabic-speaking patients with PD.
帕金森病睡眠量表(PDSS)由运动障碍协会特别工作组推荐,用于筛查和分级帕金森病(PD)睡眠问题的严重程度。本研究旨在检验阿拉伯语版PDSS - 2的有效性和可靠性。
本横断面研究对133例符合PD诊断标准的患者进行。使用以下量表对患者进行临床评估:运动障碍协会统一帕金森病评定量表(MDS - UPDRS)、改良Hoehn和Yahr量表(H&Y)、非运动症状量表(NMSS)、贝克抑郁量表(BDI)和匹兹堡睡眠质量指数(PSQI)。PDSS - 2量表按照认可的翻译标准翻译成阿拉伯语,然后再回译成英语。要求患者根据过去一周的经历进行回答。
纳入的PD患者的平均PDSS2评分为17±10。克朗巴哈α系数值为0.89,表明内部一致性良好。大多数项目显示出较高的项目 - 总分相关性;最低为0.375,高于传统的0.3截止值。重测信度显示出良好的一致性(ICC:0.848)。探索性因素分析表明,项目加载在四个因素上。PDSS - 2总分与年龄、病程、改良H&Y量表、MDS - UPDRS、NMSS、BDI和全球PSQI评分呈正相关。截止点为13时,可将睡眠差者与睡眠好者区分开来,敏感性为91%,特异性为70%(AUC 0.893,P<0.001)。
阿拉伯语版PDSS - 2具有适当的有效性,可可靠地用于评估讲阿拉伯语的PD患者的睡眠相关问题。